Protagenic Therapeutics executive chair Garo H. Armen acquires 2,700 common shares for $945
PTIX•Insider share purchase
- Garo H. Armen, executive chair and principal officer, bought 2,700 Protagenic Therapeutics common shares at USD 0.35.
- Direct common stock holdings increased to 36,899 shares.
